Eric Stern, from Yale University (Connecticut, USA), and colleagues have developed miniature nanosensors capable of detecting cancers. Utilizing a small quantity of blood collected from a patient, the sensors detect a particular protein in the blood with a high specificity and accuracy. In a two-stage approach, a microfluidic purification chip simultaneously captures multiple biomarkers from blood samples and releases them, after washing, into purified buffer for sensing by a silicon nanoribbon detector. The technology was capable of detecting two model cancer antigens from a 10 uL sample of whole blood in less than 20 minutes. Commenting that: “ This study marks the first use of label-free nanosensors with physiological solutions, positioning this technology for rapid translation to clinical settings,” the researchers are hopeful that this technology will translate into quick, easy and low-cost tests that can are performed in the doctor’s office to detect cancer with a high degree of accuracy.
Nanosensors Able to Detect Cancers

Yale University (USA) researchers develop miniature nanosensors capable of detecting cancers via a blood sample, in as little as 20 minutes.
Eric Stern, Aleksandar Vacic, Nitin K. Rajan, Jason M. Criscione, Jason Park, Bojan R. Ilic, David J. Mooney, Mark A. Reed, Tarek M. Fahmy. “Label-free biomarker detection from whole blood.” Nature Nanotechnology (13 December 2009) doi:10.1038/nnano.2009.353 Letter.
RELATED ARTICLES